|
|
|
|
Anti-CDKN3 / KAP Antibody (aa33-59, PE) LS-C207143
Most Popular CDKN3 / KAP Antibodies
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|
|
Details
| Human CDKN3 / KAP | |
| Rabbit | |
| Human, Mouse (tested or 100% immunogen sequence identity) | |
| IgG Polyclonal | |
| Phycoerythrin. Also available Unconjugated or conjugated with AP, APC, Biotin, FITC, HRP. | |
| Protein A purified | |
| Unmodified |
Applications
- Western blot
- ELISA
- (applications tested for the base form of this product only)
Specificity and Use
| CDKN3 / KAP antibody was raised against kLH-conjugated synthetic peptide (aa33-59) from human KAP. | |
| aa33-59 | |
| Human CDKN3 / KAP | |
| The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. |
Packaging
| PBS, no preservatives added | |
| May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months. | |
| For research use only. |
About CDKN3 / KAP
Q16667
NM_005192
NP_005183.2
CDKN3 Antibody, CIP2 Antibody, Kinase-associated phosphatase Antibody, KAP Antibody, KAP1 Antibody, CDI1 Antibody, CDK-associated phosphatase Antibody, Kinase associated phosphatase Antibody
CDKN3 encodes a dual specificity protein phosphatase which has been identified as a cyclin-dependent kinase inhibitor and has been shown to interact with, and dephosphorylate human CDK2 kinase. CDKN3 has also been shown to associate with human CDK3 and CDC2. The protein has been reported to remove phosphate from tyrosine residues in model substrates in vitro; however, a mutant protein that bears a lesion in the putative active site cysteine has been shown to lose catalytic activity.
Print This Page
Technical Help
Review This Product
Requested From:
Date Requested: 8/16/2017
Date Requested: 8/16/2017
